Motion Sickness Medications and Vestibular Time Constant
Raktažodžiai
Santrauka
Datos
Paskutinį kartą patikrinta: | 07/31/2017 |
Pirmasis pateikimas: | 04/01/2017 |
Numatytas registravimas pateiktas: | 08/30/2017 |
Pirmas paskelbtas: | 08/31/2017 |
Paskutinis atnaujinimas pateiktas: | 08/30/2017 |
Paskutinis atnaujinimas paskelbtas: | 08/31/2017 |
Faktinė studijų pradžios data: | 05/31/2017 |
Numatoma pirminio užbaigimo data: | 02/28/2018 |
Numatoma studijų užbaigimo data: | 04/30/2018 |
Būklė ar liga
Intervencija / gydymas
Drug: Bonine 25Mg Chewable Tablet
Drug: Kwells
Drug: Placebo Oral Tablet
Fazė
Rankų grupės
Ranka | Intervencija / gydymas |
---|---|
Active Comparator: Responsive to Scopolamine (Active) Scopolamine administration - subject will take 1 tablet per os (Kwells, Hyoscine Hydrobromide 0.3mg, 1*day ) | |
Placebo Comparator: Responsive to Scopolamine (Placebo) Placebo administration - subject will take 1 tablet per os (Placebo Oral Tablet, no active substance in the tablet) | |
Active Comparator: Non-responsive to Scopolamine (Active) Scopolamine administration - subject will take 1 tablet per os (Kwells, Hyoscine Hydrobromide 0.3mg, 1*day ) | |
Placebo Comparator: Non-responsive to Scopolamine (Placebo) Placebo administration - subject will take 1 tablet per os (Placebo Oral Tablet, no active substance in the tablet) | |
Active Comparator: Responsive to Meclizine (Active) Meclizine administration - subject will take 1 tablet per os (Bonine 25Mg Chewable Tablet, Meclizine Hydrochloride 25mg, 1*day ) | |
Placebo Comparator: Responsive to Meclizine (Placebo) Placebo administration - subject will take 1 tablet per os (Placebo Oral Tablet, no active substance in the tablet) | |
Active Comparator: Non-responsive to Meclizine (Active) Meclizine administration - subject will take 1 tablet per os (Bonine 25Mg Chewable Tablet, Meclizine Hydrochloride 25mg, 1*day ) | |
Placebo Comparator: Non-responsive to Meclizine (Placebo) Placebo administration - subject will take 1 tablet per os (Placebo Oral Tablet, no active substance in the tablet) |
Tinkamumo kriterijai
Amžius, tinkami studijuoti | 18 Years Į 18 Years |
Tinkamos studijoms lytys | Male |
Priima sveikus savanorius | Taip |
Kriterijai | Inclusion Criteria: - Healthy soldiers between the ages of 18 to 40, who suffering from sea sickness - 48 hours prior to session without any use of medications - Soldiers who vomit in waves 1.5 meter high without drugs treatment Exclusion Criteria: - Anamnestic hearing Impairment - Ear infection of any kind - Pathological finding in an otoneurological examination, witch will be done by a trained neurophysiologist / a physician. In any case of pathological finding, patient will be advised to continue medical assesment. - Vision pathologies the interfere with VNG test. - Withdrawal of informed consent by the patient of any cause. |
Rezultatas
Pirminės rezultatų priemonės
1. Vestibular Time Constant Change/differential [Baseline at the beginning of session prior to comparator (drug/placebo) receiving, 1 hour after receiving comparator and 2 hours after receiving comparator.]
2. Step Velocity Test Gain Change/differential [Baseline at the beginning of session prior to comparator (drug/placebo) receiving, 1 hour after receiving comparator and 2 hours after receiving comparator.]
3. Optokinetic After Nystagmus (OKAN) Gain Change/differential [Baseline at the beginning of session prior to comparator (drug/placebo) receiving, 1 hour after receiving comparator and 2 hours after receiving comparator.]
4. Optokinetic After Nystagmus (OKAN) Time Constant Change/differential [Baseline at the beginning of session prior to comparator (drug/placebo) receiving, 1 hour after receiving comparator and 2 hours after receiving comparator.]
5. Optokinetic After Nystagmus (OKAN) Slow Phase velocity Sum Change/differential [Baseline at the beginning of session prior to comparator (drug/placebo) receiving, 1 hour after receiving comparator and 2 hours after receiving comparator.]
6. Pupil Size Change/differential [Baseline at the beginning of session prior to comparator (drug/placebo) receiving, 1 hour after receiving comparator and 2 hours after receiving comparator.]
7. Pupil Accommodation and Convergation Change/differential [Baseline at the beginning of session prior to comparator (drug/placebo) receiving, 1 hour after receiving comparator and 2 hours after receiving comparator.]
8. Side Effects Questionnaire Change/differential [Baseline at the beginning of session prior to comparator (drug/placebo) receiving, 1 hour after receiving comparator and 2 hours after receiving comparator.]